HALKUFF DAWN

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 295%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
HALKUFF DAWN's trades of Xeris Biopharma Holdings, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
255.79
Quantity 51,958
Value US$4,463,411
Transaction date
Proposed sale
Price
7.28
Quantity 42,500
Value US$309,226
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04
PlS Planned sale
82,442 +39.4%
415.93
US$1,555,943 		82,442 +39.4% 415.93 US$1,555,943
2026-06-04 2026-06-04
PrS Proposed sale
51,958
255.79
US$4,463,411 		51,958 255.79 US$4,463,411
2025-08-13 2025-08-12
S Sale
22,238 +42.9%
293.62
US$4,485,336 		22,238 +42.9% 293.62 US$4,485,336
2025-08-12 2025-08-12
PrS Proposed sale
42,500
7.28
US$309,226 		42,500 7.28 US$309,226
2023-11-21 2023-11-20
B Purchase
5,410 New position
1.84
US$9,954 		5,410 New position 1.84 US$9,954